Merit Medical(MMSI)

Search documents
Merit Medical(MMSI) - 2021 Q1 - Earnings Call Transcript
2021-05-01 00:18
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q1 2021 Earnings Conference Call April 29, 2021 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman & Chief Executive Officer Brian Lloyd - Chief Legal Officer & Corporate Secretary Raul Parra - Chief Financial Officer & Treasurer Conference Call Participants Jayson Bedford - Raymond James Steven Lichtman - Oppenheimer Matthew O'Brien - Piper Sandler Mike Matson - Needham Shagun Singh Chadha - Wells Fargo Jim Sidoti - Sidoti & Company Operator Goo ...
Merit Medical(MMSI) - 2020 Q4 - Annual Report
2021-03-01 17:51
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2020 or ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. for the transition period from to . Commission File Number 0-18592 MERIT MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Utah 87-0447695 (State or ...
Merit Medical(MMSI) - 2020 Q4 - Earnings Call Transcript
2021-02-25 04:45
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q4 2020 Earnings Conference Call February 24, 2021 5:00 PM ET Company Participants Fred Lampropoulos - Chairman, CEO & President Brian Lloyd - Chief Legal Officer & Corporate Secretary Raul Parra - CFO & Treasurer Conference Call Participants Michael Matson - Needham & Company Steven Lichtman - Oppenheimer James Sidoti - Sidoti & Company Jayson Bedford - Raymond James & Associates Michael Petusky - Barrington Research Associates Doug Free - World Capital Group Opera ...
Merit Medical(MMSI) - 2020 Q3 - Quarterly Report
2020-11-05 20:55
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission File Number 0-18592 MERIT MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction ...
Merit Medical(MMSI) - 2020 Q3 - Earnings Call Transcript
2020-10-29 05:28
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q3 2020 Earnings Conference Call October 28, 2020 5:00 PM ET Company Participants Fred Lampropoulos - Chief Executive Officer Brian Lloyd - Chief Legal Officer Raul Parra - Chief Financial Officer Conference Call Participants Matthew O'Brien - Piper Sandler Jayson Bedford - Raymond James Mike Matson - Needham & Company Steve Lichtman - Oppenheimer Mike Petusky - Barrington Research Jim Sidoti - Sidoti & Company Operator Good afternoon, ladies and gentlemen, and welc ...
Merit Medical(MMSI) - 2020 Q2 - Quarterly Report
2020-08-06 20:51
MERIT MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Utah 87-0447695 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) 1600 West Merit Parkway, South Jordan, Utah 84095 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT ...
Merit Medical(MMSI) - 2020 Q2 - Earnings Call Transcript
2020-07-30 16:34
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q2 2020 Earnings Conference Call July 29, 2020 5:00 PM ET Company Participants Fred Lampropoulos - Chief Executive Officer Brian Lloyd - Chief Legal Officer Raul Parra - Chief Financial Officer Conference Call Participants Larry Biegelsen - Wells Fargo Steve Lichtman - Oppenheimer Cecilia Furlong - Canaccord Mike Petusky - Barrington Research Jayson Bedford - Raymond James Jim Sidoti - Sidoti & Company Mike Matson - Needham & Company Matthew O'Brien - Piper Sandler ...
Merit Medical(MMSI) - 2020 Q1 - Quarterly Report
2020-05-11 19:51
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission File Number 0-18592 MERIT MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Utah 87-0447695 (State or other ...
Merit Medical(MMSI) - 2020 Q1 - Earnings Call Transcript
2020-04-24 05:54
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q1 2020 Earnings Conference Call April 23, 2020 5:00 PM ET Company Participants Fred Lampropoulos - Chief Executive Officer Brian Lloyd - Chief Legal Officer and Corporate Secretary Raul Parra - Chief Financial Officer Conference Call Participants Shagun Singh - Wells Fargo Securities Michael Matson - Needham & Company, LLC Matthew O???Brien - Piper Sandler Jayson Bedford - Raymond James Financial Steven Lichtman - Oppenheimer & Co. Inc. Cecilia Furlong - Canaccord ...
Merit Medical(MMSI) - 2019 Q4 - Annual Report
2020-03-02 21:40
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2019 or ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. for the transition period from to . Commission File Number 0-18592 MERIT MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Utah 87-0447695 (State or ...